论文部分内容阅读
Objectives: Phosphatidylinositol-3 kinase (PI3K)/Akt signaling represents a key survival mechanism in cancer cells and has emerged as an attractive cancer therapeutic target.NVP-BKM120 (BKM120) is a new pan class Ⅰ PI3K inhibitor that suppresses this pathway.